Clinical Trial Update: TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography [NA]

View source ↗

Summary

The TRUST-ACE trial investigates using echocardiography to identify cardiotoxicity from anticancer treatments, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Breast Neoplasm Malignant Primary | NA | Status: RECRUITING